Canaccord Genuity Group Analysts Give Vitalhub (TSE:VHI) a C$15.00 Price Target

Canaccord Genuity Group set a C$15.00 target price on Vitalhub (TSE:VHI) in a research report sent to investors on Friday morning,BayStreet.CA reports. The firm currently has a buy rating on the stock.

Separately, National Bank Financial reduced their target price on shares of Vitalhub from C$14.00 to C$11.00 and set an “outperform” rating on the stock in a research note on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating and six have given a Buy rating to the stock. According to data from MarketBeat, Vitalhub presently has a consensus rating of “Buy” and an average target price of C$13.00.

Vitalhub Stock Performance

Shares of VHI opened at C$8.61 on Friday. Vitalhub has a fifty-two week low of C$6.46 and a fifty-two week high of C$12.72. The stock has a market capitalization of C$545.35 million, a PE ratio of 71.75, a P/E/G ratio of 1.18 and a beta of 0.91. The company’s fifty day moving average is C$7.36 and its 200 day moving average is C$7.51.

Vitalhub (TSE:VHI) last posted its earnings results on Thursday, August 6th. The company reported C$0.03 earnings per share for the quarter. The firm had revenue of C$31.74 million for the quarter. Vitalhub had a net margin of 5.89% and a return on equity of 2.79%. As a group, research analysts forecast that Vitalhub will post 0.2296467 earnings per share for the current year.

Vitalhub Company Profile

VitalHub is a leading software company dedicated to empowering health and human services providers globally. VitalHub’s comprehensive product suite includes electronic health records, operational intelligence, and workforce automation solutions that serve over 1,300 clients across the UK, Canada, and other geographies. The Company has a robust two-pronged growth strategy, targeting organic opportunities within its product suite and pursuing an aggressive M&A plan. VitalHub is headquartered in Toronto with over 700 employees globally, across key regions and the VitalHub Innovations Lab in Sri Lanka.